MY201389A - Oral composition - Google Patents

Oral composition

Info

Publication number
MY201389A
MY201389A MYPI2020002889A MYPI2020002889A MY201389A MY 201389 A MY201389 A MY 201389A MY PI2020002889 A MYPI2020002889 A MY PI2020002889A MY PI2020002889 A MYPI2020002889 A MY PI2020002889A MY 201389 A MY201389 A MY 201389A
Authority
MY
Malaysia
Prior art keywords
oral composition
component
provides
present
collagen layer
Prior art date
Application number
MYPI2020002889A
Inventor
Yumiko Kakinoki
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of MY201389A publication Critical patent/MY201389A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An object of the present invention is to provide an oral composition that is capable of efficiently inhibiting the decomposition of a collagen layer inside dentine when the collagen layer is exposed, and to provide a use for the oral composition. The present invention provides an oral composition that contains: a component (A): glycerophosphoric acid and/or a salt thereof; and a component (B): pyrrolidone carboxylic acid and/or an inorganic base salt thereof, and provides a use of the oral composition.
MYPI2020002889A 2017-12-13 2018-12-12 Oral composition MY201389A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017238507 2017-12-13
PCT/JP2018/045750 WO2019117211A1 (en) 2017-12-13 2018-12-12 Composition for use in oral cavity

Publications (1)

Publication Number Publication Date
MY201389A true MY201389A (en) 2024-02-21

Family

ID=66819297

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2020002889A MY201389A (en) 2017-12-13 2018-12-12 Oral composition

Country Status (5)

Country Link
JP (1) JP7073402B2 (en)
KR (1) KR102642592B1 (en)
CN (1) CN111479553B (en)
MY (1) MY201389A (en)
WO (1) WO2019117211A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0523386A (en) 1991-07-23 1993-02-02 Mitsubishi Materials Corp Calcium phosphate cement
JP4759149B2 (en) 2000-03-06 2011-08-31 株式会社クラレ Dental composition
KR100511104B1 (en) 2001-10-15 2005-08-31 창원특수강주식회사 A method for spray casting of alloy ingots
JP4542843B2 (en) * 2003-07-15 2010-09-15 花王株式会社 Oral composition
US8557224B2 (en) * 2003-07-15 2013-10-15 Kao Corporation Oral cavity composition
JP2005047855A (en) * 2003-07-29 2005-02-24 Lion Corp Oral biofilm inhibitor and oral composition
JP2011140454A (en) 2010-01-06 2011-07-21 Sunstar Inc Composition for oral cavity
EP2380565A1 (en) * 2010-03-31 2011-10-26 Lunamed AG Compositions for dental treatment comprising Lipoteichoic acids or parts thereof like mono- or polyglycerphosphates
KR101950661B1 (en) 2011-09-28 2019-02-20 라이온 가부시키가이샤 Oral composition
JP2016121089A (en) * 2014-12-25 2016-07-07 ライオン株式会社 Oral composition
JP6471667B2 (en) * 2015-09-28 2019-02-20 ライオン株式会社 Liquid oral composition

Also Published As

Publication number Publication date
KR20200098479A (en) 2020-08-20
KR102642592B1 (en) 2024-03-05
JPWO2019117211A1 (en) 2020-10-22
JP7073402B2 (en) 2022-05-23
CN111479553A (en) 2020-07-31
WO2019117211A1 (en) 2019-06-20
CN111479553B (en) 2023-02-24

Similar Documents

Publication Publication Date Title
IL279034A (en) Pharmaceutical combination, composition and formulation containing glucokinase activator and α-glucosidase inhibitor, preparation methods therefor and uses thereof
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
JOP20200122B1 (en) Compounds useful for inhibiting cdk7
PH12020550703A1 (en) Sulfonamide compounds and use thereof
SA517390322B1 (en) (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
MY174149A (en) Composition for oral cavity
PH12019502646A1 (en) Pyrazole magl inhibitors
MX2017008518A (en) Isoquinoline compounds for the treatment of hiv.
EA201990159A1 (en) BIARYLMETHyl HETEROCYCLES
EA201890858A1 (en) 2,4-DIHYDROXINICOTINAMIDES AS APJ AGONISTS
MX2021003792A (en) Benzoquinoline inhibitors of vesicular monoamine transporter 2.
SG11201907472QA (en) Composition for inhibiting myofibrosis
MX2022006518A (en) Extended release pharmaceutical composition of clozapine.
ZA202108987B (en) 1-amino-1-cyclopropanecarboxylic acid hudrochloride formulations
MX376624B (en) COMPOSITION OF STABLE STORAGE SOLID PEROXYMONOSULFATE.
PH12015502211B1 (en) Oral composition
GEAP202115141A (en) Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor
EP4249072A3 (en) Crystalline forms of quinolone analogs and their salts
MX2021005390A (en) Novel amorphous active pharmaceutical ingredients comprising substantially amorphous mesoporous magnesium carbonate.
PH12016502386B1 (en) Oral care compositions
MY201389A (en) Oral composition
MX2014008336A (en) Antihyperalgesic, antiallodynic and anti-inflammatory pharmacological combination, pharmaceutical compositions containing same and use thereof for treating neuropatic pain.
PH12017501897A1 (en) 2-thiopyrimidinones
MX2021011736A (en) DEODORANT COMPOSITIONS.